---
title: Colloid Osmotic Pressure in Patients With Fontan Circulation
nct_id: NCT02443662
overall_status: COMPLETED
sponsor: Oslo University Hospital
study_type: OBSERVATIONAL
primary_condition: Heart Defects, Congenital
countries: Norway
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02443662.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02443662"
ct_last_update_post_date: 2018-04-18
last_seen_at: "2026-05-12T07:00:43.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Colloid Osmotic Pressure in Patients With Fontan Circulation

**Official Title:** Interstitial Colloid Osmotic Pressure in Children With Fontan Circulation After Fontan Surgery

**NCT ID:** [NCT02443662](https://clinicaltrials.gov/study/NCT02443662)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 12
- **Lead Sponsor:** Oslo University Hospital
- **Collaborators:** University of Bergen
- **Conditions:** Heart Defects, Congenital
- **Start Date:** 2015-09
- **Completion Date:** 2018-01
- **CT.gov Last Update:** 2018-04-18

## Brief Summary

Children born with univentricular heart will go through step surgery and end up with a Fontan circulation. A circulation with cause problems with body fluid balance.This project will evaluate changes in interstitial colloid osmotic pressure in patients 10 year after completion of a three step Fontan surgery. This project will evaluate whether increased micro vascular leakage and change in interstitial colloid osmotic pressure are present in patients after ten years with a Fontan circulation.

## Eligibility

- **Minimum age:** 13 Years
- **Maximum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Fontan circulation after completed Fontan surgery.
* Anesthesia during catheterization.

Exclusion Criteria:

* No consent
```

## Interventions

- **Catheterization** (OTHER) — Routine catheterization during follow up.

## Primary Outcomes

- **Interstitial colloid osmotic pressure** _(time frame: Ten years after completed Fontan surgery)_

## Locations (1)

- Oslo University Hospital, Oslo, Norway

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.oslo university hospital|oslo||norway` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02443662.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02443662*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*